Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
METTL22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ABAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM114 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM186 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PMM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CARHSP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBFOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EEF2KMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAGPA-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C16orf89 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAGPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on